Search

Your search keyword '"Luisa Ricaurte"' showing total 16 results
Start Over Author "Luisa Ricaurte" Journal journal of thoracic oncology
16 results on '"Luisa Ricaurte"'

1. PD.01.03 Genomic Landscape of Primary-Resistance to Osimertinib among Hispanic Patients With EGFR-Mutant Non-Small-Cell Lung Cancer: Results of an Observational Longitudinal-Cohort Study

Author

Diego Chamorro, Andres Cardona, July Rodriguez, Alejandro Ruiz-Patiño, Oscar Arrieta, Darwin Moreno-Perez, Leonardo Rojas, Zyanya Lucia Zatarain-Barrón, Dora Ardila, Lucia Viola, Gonzalo Recondo, Juan B. Blaquier, Claudio Martin, Luis E. Raez, Suraj Samtani, Camila Ordoñez-Reyes, Juan Esteban Garcia-Robledo, Luis Corrales, Carolina Sotelo, Luisa Ricaurte, Mauricio Cuello, Sergio Mejia, Elvira Jaller, Carlos Vargas, Alessandro Russo, Umberto Malapelle, Diego de Miguel Perez, Vladmir C. Cordeiro de Lima, Helano Freitas, Christian Rolfo, and Rafael Rosell

Subjects
Pulmonary and Respiratory Medicine, Oncology
Published
2023
Full Text
View/download PDF

2. Atypical skin manifestations during immune checkpoint blockage in coronavirus disease 2019–infected patients with lung cancer

Author

Alejandro Ruiz-Patiño, Christian Rolfo, Andrés F. Cardona, Lucia Viola, Oscar Arrieta, Luisa Ricaurte, Leonardo Rojas, Santiago Ariza, Alessandro Russo, Lucia Zatarain-Barrón, Luis Eduardo Pino, Cardona-Mendoza, Andrés Felipe [0000-0002-6697-5471], Rojas Puentes, Leonardo [0000-0002-7865-5424], and Viola Muñoz, Lucía [0000-0002-1647-2884]

Subjects
0301 basic medicine, Vasculitis, Male, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, Population, Pneumonia, Viral, medicine.disease_cause, Skin Diseases, B7-H1 Antigen, law.invention, 03 medical and health sciences, Betacoronavirus, 0302 clinical medicine, law, Internal medicine, Diabetes mellitus, medicine, Humans, Erythema multiforme, education, Lung cancer, Pandemics, Coronavirus, education.field_of_study, business.industry, SARS-CoV-2, Cancer, COVID-19, Middle Aged, medicine.disease, Anti–PD-1 therapy, Intensive care unit, Urticarial, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, business, Coronavirus Infections
Abstract

A new coronavirus, named severe acute respiratory syndrome-coronavirus-2 by the WHO, has rapidly spread around the world since its first reported case in late December of 2019 from Wuhan, the People's Republic of China. As of mid-April 2020, this virus has affected more than 180 countries and territories, infecting more than 1,650,000 individuals and causing over 100,000 deaths. With approximately 20 million new cases globally per year, cancer affects a substantial portion of the population. Individuals affected by cancer are more susceptible to infections owing to coexisting chronic diseases (cardiovascular, pulmonary, and diabetes), overall poor health status, and systemic immunosuppressive states caused by both cancer and the anticancer treatment. As a consequence, patients with malignancies, especially those with lung cancer who develop coronavirus disease 2019, experience more difficult outcomes. A recent multicenter study carried out by the Hubei Anti-Cancer Association has also documented that patients with lung cancer had an increased risk of death, intensive care unit requirement, risk of presenting severe or critical symptoms, and use of invasive mechanical ventilation. Here, we present two representative cases of patients with lung cancer and coronavirus disease 2019 without respiratory compromise and with atypical and severe skin manifestations-findings that could be influenced by the long-term use of anti-programmed cell death protein 1 antibody.

Published
2020
Full Text
View/download PDF

3. P1.12 Real World Characterization and Treatment Patterns of Patients with Thymic Carcinoma: Lessons from a Latin American Collaborative Study (CLICaP-LATimus)

Author

Rosa Rosell, M. Corassa, Pilar Archila, Patricia Rioja, Luisa Ricaurte, L. Zatarain Barron, L. Corrales-Rodriguez, S. Lozano, Alejandro Ruiz-Patiño, Jordi Remon, R. Ruiz, T. Soria, Oscar Arrieta, Carlos Vargas, Luis Mas, M. Bravo, J. Ávila, Ana Karina Patané, Jorge Otero, C. Sotelo, Andrés Felipe Cardona, Hernán Carranza, Feliciano Barrón, D. Mayorga, C. Martin, July Rodriguez, Helano C. Freitas, and V. Cordeiro De Lima

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Latin Americans, business.industry, Internal medicine, medicine, medicine.disease, business, Thymic carcinoma
Published
2019
Full Text
View/download PDF

4. PD2.06 EGFR Inhibitors + Bevacizumab Demonstrated Superior Efficacy Compared with EGFR Inhibitors Alone as First-line Treatment in Advanced NSCLC Patients with EGFR Mutations and BIM Deletion Polymorphisms

Author

J. Ávila, Luis Mas, Feliciano Barrón, L. Corrales-Rodriguez, Helano C. Freitas, C. Martin, Rosa Rosell, C. Sotelo, Pilar Archila, L. Zatarain Barron, Andrés Felipe Cardona, Alejandro Ruiz-Patiño, Carlos Vargas, V. Cordeiro De Lima, Hernán Carranza, Oscar Arrieta, D. Mayorga, July Rodriguez, Jorge Otero, and Luisa Ricaurte

Subjects
Pulmonary and Respiratory Medicine, First line treatment, Oncology, Bevacizumab, Egfr mutation, business.industry, medicine, Cancer research, business, medicine.drug, EGFR inhibitors
Published
2019
Full Text
View/download PDF

5. P1.10 Survival of Thymoma Is Extensive in Latin-American Patients: Results from over 10 Years of Experience (CLICaP-LATimus)

Author

C. Sotelo, Jorge Otero, Hernán Carranza, Andrés Felipe Cardona, D. Mayorga, Helano C. Freitas, Rosa Rosell, Carlos Vargas, M. Bravo, C. Martin, Alejandro Ruiz-Patiño, M. Corassa, Pilar Archila, Patricia Rioja, J. Ávila, V. Cordeiro De Lima, Luisa Ricaurte, S. Lozano, Jordi Remon, L. Corrales-Rodriguez, Ana Karina Patané, T. Soria, Luis Mas, Oscar Arrieta, R. Ruiz, Feliciano Barrón, July Rodriguez, and L. Zatarain Barron

Subjects
Pulmonary and Respiratory Medicine, medicine.medical_specialty, Thymoma, Latin Americans, Oncology, business.industry, General surgery, Medicine, business, medicine.disease
Published
2019
Full Text
View/download PDF

6. P2.23 Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy

Author

C. Sotelo, Oscar Arrieta, Hernán Carranza, Manglio Rizzo, R. Ruiz Mendoza, Feliciano Barrón, L. Zatarain Barron, Rosa Rosell, July Rodriguez, C. Bas, Carlos Ortiz, Luisa Ricaurte, F. Perazzo, C. Pupareli, Christian D. Rolfo, C. Martin, Jorge Otero, Luis Mas, Pilar Archila, O. Carranza, L. Corrales-Rodriguez, L. Lupinacci, M.A. Bravo-Garzón, P. Laguado, L. Rojas, Luis E. Raez, Carlos Vargas, Andrés Felipe Cardona, Luis Eduardo Pino, and Alejandro Ruiz-Patiño

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Internal medicine, Medicine, Immunotherapy, business
Published
2019
Full Text
View/download PDF

7. P2.25 Immunotherapy at Any Line of Treatment Improves Survival in Hispanic Patients with Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) Compared with Chemotherapy (Quijote-CLICaP)

Author

L. Zatarain Barron, Carlos Vargas, Rosa Rosell, Luisa Ricaurte, Feliciano Barrón, Manglio Rizzo, P. Laguado, R. Ruiz Mendoza, Christian D. Rolfo, C. Sotelo, C. Bas, O. Carranza, L. Rojas, Pilar Archila, Hernán Carranza, Oscar Arrieta, L. Lupinacci, Luis E. Raez, Jorge Otero, Luis Eduardo Pino, July Rodriguez, Andrés Felipe Cardona, C. Pupareli, C. Martin, M.A. Bravo-Garzón, Alejandro Ruiz-Patiño, Luis Mas, Carlos Ortiz, F. Perazzo, and L. Corrales-Rodriguez

Subjects
Pulmonary and Respiratory Medicine, Oncology, Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, non-small cell lung cancer (NSCLC), Immunotherapy, medicine.disease, Internal medicine, Medicine, Line (text file), business
Published
2019
Full Text
View/download PDF

8. EP1.15-29 Real World Characterization and Treatment of Patients with Thymic Carcinoma: Lessons from a Latin-American Study (CLICaP-LATimus)

Author

Carlos Vargas, Jorge Otero, S. Lozano, Rossana Ruiz, Luisa Ricaurte, Ana Karina Patané, Andrés Felipe Cardona, July Rodriguez, Oscar Arrieta, D. Mayorga, C. Sotelo, C. Martin, L. Rojas, Alejandro Ruiz-Patiño, Hernán Carranza, Z.L. Zatarain Barrón, Rosa Rosell, Pilar Archila, Patricia Rioja, Luis Corrales, Luis Mas, M. Corassa, M. Bravo, Jordi Remon, J. Ávila, Helano C. Freitas, V. Cordeiro De Lima, and T. Soria

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Latin Americans, business.industry, Internal medicine, medicine, medicine.disease, business, Thymic carcinoma
Published
2019
Full Text
View/download PDF

9. EP1.04-46 Immunotherapy at Any Line Improves Survival in Hispanic Patients with Advanced Metastatic NSCLC Compared to Chemotherapy (Quijote-CLICaP)

Author

Feliciano Barrón, Carmen Puparelli, Oscar Arrieta, C. Martin, Carlos Ortiz, Rosa Rosell, Luis Corrales, Carlos Vargas, Christian D. Rolfo, Pilar Archila, Luis Eduardo Pino, L. Lupinacci, July Rodriguez, C. Sotelo, Andrés Felipe Cardona, F. Perazzo, P. Laguado, R. Ruiz, M.A. Bravo-Garzón, Hernán Carranza, L. Rojas, Luis E. Raez, O. Carranza, Luisa Ricaurte, Alejandro Ruiz-Patiño, C. Bas, Jorge Otero, Z.L. Zatarain Barrón, Luis Mas, and Manglio Rizzo

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Chemotherapy, business.industry, Internal medicine, medicine.medical_treatment, medicine, Immunotherapy, Line (text file), business
Published
2019
Full Text
View/download PDF

10. P02 EGFR Amplification and Sensitizing Mutations Correlates with Survival from Erlotinib in Lung Adenocarcinoma Patients

Author

Hernán Carranza, July Rodriguez, Christian David Castro, L. Rojas, C. Martin, M. Bravo, Carlos Vargas, Noemí Reguart, Jorge Otero, Z. Zatarain-Barrón, Alejandro Ruiz-Patiño, Luisa Ricaurte, A. Cardona, Oscar Arrieta, Luis Corrales, Beatriz Wills, Luis Eduardo Pino, J. Avila, Rosa Rosell, and Pilar Archila

Subjects
Pulmonary and Respiratory Medicine, Lung, medicine.anatomical_structure, Oncology, business.industry, EGFR Amplification, medicine, Cancer research, Adenocarcinoma, Erlotinib, medicine.disease, business, medicine.drug
Published
2018
Full Text
View/download PDF

11. P2.22 Immunotherapy-related Thrombosis: Considerations and Associated Factors in Non-small Cell Lung Cancer (NSCLC) Patients

Author

Luisa Ricaurte, L. Zatarain Barron, July Rodriguez, Rosa Rosell, J. Ávila, Carlos Vargas, Oscar Arrieta, C. Martin, L. Corrales-Rodriguez, Pilar Archila, Andrés Felipe Cardona, Alejandro Ruiz-Patiño, Feliciano Barrón, Helano C. Freitas, C. Sotelo, Hernán Carranza, Jorge Otero, V. Cordeiro De Lima, D. Mayorga, and Luis Mas

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Internal medicine, medicine, non-small cell lung cancer (NSCLC), Immunotherapy, medicine.disease, business, Thrombosis
Published
2019
Full Text
View/download PDF

12. PD2.03 Exploration of Factors Relating to Immune Response in Patients Treated with Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (NSCLC)

Author

Carlos Vargas, Andrés Felipe Cardona, C. Sotelo, Luisa Ricaurte, Rosa Rosell, Oscar Arrieta, Hernán Carranza, L. Zatarain Barron, D. Mayorga, Pilar Archila, Helano C. Freitas, V. Cordeiro De Lima, Alejandro Ruiz-Patiño, C. Martin, Jorge Otero, J. Ávila, Feliciano Barrón, Luis Mas, July Rodriguez, and L. Corrales-Rodriguez

Subjects
Pulmonary and Respiratory Medicine, Immune system, Oncology, business.industry, Immune checkpoint inhibitors, Cancer research, Medicine, non-small cell lung cancer (NSCLC), In patient, business, medicine.disease
Published
2019
Full Text
View/download PDF

13. EP1.04-44 Exploration of Factors Relating to Paradoxical Immune Response in Patients Treated with Immune Checkpoint Inhibitors for NSCLC

Author

C. Sotelo, Hernán Carranza, D. Mayorga, Luis Corrales, Andrés Felipe Cardona, Rosa Rosell, Pilar Archila, Alejandro Ruiz-Patiño, V. Cordeiro De Lima, M. Bravo, J. Ávila, Z.L. Zatarain Barrón, Luis Mas, Helano C. Freitas, Luisa Ricaurte, Oscar Arrieta, Feliciano Barrón, July Rodriguez, C. Martin, L. Rojas, Jorge Otero, and Carlos Vargas

Subjects
Pulmonary and Respiratory Medicine, Immune system, Oncology, business.industry, Immune checkpoint inhibitors, Immunology, Medicine, In patient, business
Published
2019
Full Text
View/download PDF

14. P1.14-61 EGFR Inhibitors Plus Bevacizumab Are Superior Compared to EGFR Inhibitor Monotherapy in Advanced EGFR+ NSCLC Patients with BIM Deletions

Author

C. Martin, Rosa Rosell, Pilar Archila, Luisa Ricaurte, V. Cordeiro De Lima, Luis Mas, Carlos Vargas, Feliciano Barrón, Andrés Felipe Cardona, C. Sotelo, L. Rojas, Jorge Otero, Luis Corrales, Hernán Carranza, Alejandro Ruiz-Patiño, D. Mayorga, J. Ávila, Helano C. Freitas, Z.L. Zatarain Barrón, Oscar Arrieta, and July Rodriguez

Subjects
Pulmonary and Respiratory Medicine, Oncology, Bevacizumab, business.industry, medicine, Cancer research, business, medicine.drug, EGFR inhibitors
Published
2019
Full Text
View/download PDF

16. P3.01-11 Depression and Inflammation in Patients with EGFR-Mutated Non-Small Cell Lung Cancer

Author

C. Martin, Carlos Vargas, Oscar Arrieta, Z. Zatarain-Barrón, A. Cardona, Hernán Carranza, Luis Corrales, Luisa Ricaurte, Jorge Otero, Alejandro Ruiz-Patiño, and L. Rojas

Subjects
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, business.industry, Inflammation, medicine.disease, Internal medicine, medicine, In patient, Non small cell, medicine.symptom, Lung cancer, business, Depression (differential diagnoses)
Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results